NIH Patents and Patent Applications

This list includes non-provisional and PCT patent filings.

CSV download of the complete patent data set.

For information on patent application codes, country codes, and patent status, see the Patents FAQ.

Tips:
Reset the Search Filters to go back to the initial display of all records.
Sort columns by clicking on the blue column headers.
The Search function searches across all columns.
To filter results by Lead IC, Country, or Application, type or use the dropdown menu.

Lead IC Reference Number Title Country Patent Application Type Application Number Date Filed Patent Number Date Issued Patent Status Patent PDF
NCI E-057-1994-2-US-04 MELANOMA ANTIGENS [MART-1 only] AND THEIR USE IN DIAGNOSTIC AND THERAPEUTIC METHODS US DIV 09/898,860 6965017 Expired PDF
NIDCR E-015-2002-0-US-01 MAMMALIAN SWEET AND AMINO ACID HETERODIMERIC TASTE RECEPTORS US 60/302,898 Abandoned
NCI E-255-2001-0-US-01 Methods And Compositions For The Diagnosis And Treatment of Cancer, Including Those Involving the Notch Pathway US 60/302,788 Abandoned
NICHD E-225-1997-5-US-01 METHODS FOR THE PRODUCTION OF PURIFIED RECOMBINANT HUMAN UTEROGLOBIN FOR THE TREATMENT OF INFLAMMATORY AND FIBROTIC CONDITIONS. US CIP 09/898,616 7122344 Expired PDF
NCI E-151-1998-0-DE-13 Water-Insoluble Drug Delivery System DE EP 99965336.3 Abandoned
NCI E-151-1998-0-FR-12 Water-Insoluble Drug Delivery System FR EP 99965336.3 Abandoned
NCI E-151-1998-0-CH-11 Water-Insoluble Drug Delivery System CH EP 99965336.3 Abandoned
NCI E-151-1998-0-IE-10 Water-Insoluble Drug Delivery System IE EP 99965336.3 Abandoned
NCI E-151-1998-0-IT-09 Water-Insoluble Drug Delivery System IT EP 99965336.3 Abandoned
NCI E-151-1998-0-GB-14 Water-Insoluble Drug Delivery System GB EP 99965336.3 Abandoned
NCI E-114-2001-0-US-01 Methods of Generating Human CD4+ Th2 Cells US 60/302,936 Abandoned
NIDDK E-070-1996-2-US-04 NOVEL METHOD OF O-DEMETHYLATION And N-Deprotection US DIV 09/895,956 6395900 Abandoned PDF
NHGRI E-242-1997-0-US-03 METHODS FOR ASSESSING GENETIC AND PHENOTYPIC MARKERS BY SIMULATANEOUS MULTICOLOR VISUALIZATION OF CHROMOGENIC DYES USING BRIGHTFIELD MICROSCOPY AND SPECTRAL IMAGING. US DIV 09/895,031 Abandoned
NCI E-151-2001-0-US-01 Method of Promoting Engraftment of a Donor Transplant in a Recipient Host US 60/302,258 Abandoned
NCI E-069-2001-0-US-01 Use of Lipoxygenase Inhibitors And PPar Ligands as Anti-Cancer Therapeutic And Intervention Agents US 60/302,155 Abandoned
NHLBI E-062-2006-0-US-02 Thymic Stromal Lymphopoietin Receptor Molecules And Uses Thereof US ORD 09/895,593 6955895 Expired PDF
NCI E-231-1998-0-US-03 Lentivirus Vector System US National Stage 09/869,588 6790657 Abandoned PDF
CC E-186-2000-0-PCT-02 Radio-Frequency Probes For Tissue Treatment and Methods of Use PCT PCT PCT/US01/20632 Expired
NICHD E-054-2000-0-PCT-02 USE AND TARGETING OF CD98 LIGHT-CHAIN PROTEINS IN THERAPIES FOR THYROID HORMONE DISORDERS PCT PCT PCT/US01/20843 Expired
NIDDK E-104-1989-0-US-13 BIOLOGICALLY ACTIVE SYNTHETIC THYROTROPIN AND CLONED GENE FOR PRODUCING SAME US FWC 09/892,266 Abandoned
NIDCR E-159-1999-0-AU-05 A Highly Efficacy, High Yield Petussis Vaccine and Method for Making Same AU National Stage 2001271495 Abandoned
NCI E-240-2001-0-US-01 Macromolecular Imaging Agents For Liver Imaging US 60/300,882 Abandoned
NIAID E-225-2000-0-BR-05 Respiratory Syncytial Virus Vaccines Expressing Protective Antigens From Promotor-Proximal Genes BR National Stage PI0112276-2 Expired
NIAID E-225-2000-0-IL-09 Respiratory Syncytial Virus Vaccines Expressing Protective Antigens From Promotor-Proximal Genes IL National Stage 153530 Abandoned
NIAID E-225-2000-0-KR-11 Respiratory Syncytial Virus Vaccines Expressing Protective Antigens From Aomotor-Proximal Genes KR National Stage 10-2002-7017577 Abandoned
NIAID E-225-2000-0-MX-12 Respiratory Syncytial Virus Vaccines Expressing Protective Antigens from Promoter-Proximal Genes MX National Stage 2002-012818 Abandoned
NIAID E-225-2000-0-NL-25 Respiratory Syncytial Virus Vaccines Expressing Protective Antigens From Promoter-Proximal Genes NL EP 01946696.0 Expired
NIAID E-225-2000-0-IT-24 Respiratory Syncytial Virus Vaccines Expressing Protective Antigens From Promoter-Proximal Genes IT EP 01946696.0 Expired
NIAID E-225-2000-0-IE-23 Respiratory Syncytial Virus Vaccines Expressing Protective Antigens From Promoter-Proximal Genes IE EP 01946696.0 Expired
NIAID E-225-2000-0-GB-22 Respiratory Syncytial Virus Vaccines Expressing Protective Antigens From Promoter-Proximal Genes GB EP 01946696.0 Expired
NIAID E-225-2000-0-CH-18 Respiratory Syncytial Virus Vaccines Expressing Protective Antigens From Promoter-Proximal Genes CH EP 01946696.0 Expired
NIAID E-225-2000-0-DE-19 Respiratory Syncytial Virus Vaccines Expressing Protective Antigens From Promoter-Proximal Genes DE EP 01946696.0 Expired
NIAID E-225-2000-0-FR-21 Respiratory Syncytial Virus Vaccines Expressing Protective Antigens From Promoter-Proximal Genes FR EP 01946696.0 Expired
NIAID E-225-2000-0-ES-20 Respiratory Syncytial Virus Vaccines Expressing Protective Antigens From Promoter-Proximal Genes ES EP 01946696.0 Expired
NIAID E-225-2000-0-BE-17 Respiratory Syncytial Virus Vaccines Expressing Protective Antigens From Promoter-Proximal Genes BE EP 01946696.0 Expired
NIAID E-225-2000-0-EP-08 Respiratory Syncytial Virus Vaccines Expressing Protective Antigens From Promoter-Proximal Genes EP National Stage 01946696.0 Expired
NIAID E-225-2000-0-AU-04 Respiratory Syncytial Virus Vaccines Expressing Protective Antigens From Promotor-Proximal Genes AU National Stage 2001268709 Abandoned
NIAID E-225-2000-0-US-02 Respiratory Syncytial Virus Vaccines Expressing Protective Antigens From Promoter-Proximal Genes US ORD 09/887,469 6923971 Expired PDF
NIAID E-093-2000-0-US-02 Methods of Diagnosing Multidrug Resistant Tuberculosis US ORD 09/888,320 6905822 Expired PDF
NCI E-059-1992-1-US-04 CALANOLIDES And Related ANTIVIRAL COMPOUNDS; COMPOSITIONS AND USES THEREOF US CON 09/887,375 6673830 Expired PDF
NIAID E-225-2000-0-PCT-03 Respiratory Syncytial Virus Vaccines Expressing Protective Antigens From Promoter-Proximal Genes PCT PCT PCT/US2001/020107 Expired
NIAID E-225-2000-0-JP-10 Respiratory Syncytial Virus Vaccines Expressing Protective Antigens From Promoter-Proximal Genes JP National Stage 10-2002-505815 Abandoned
NIDDK E-213-2001-1-US-01 Anticancer Effects of a Novel Vitamin D Receptor Antagonists US 60/300,409 Abandoned
NIAID E-225-2000-0-CA-06 Respiratory Syncytial Virus Vaccines Expressing Protective Antigens From Promotor-Proximal Genes CA National Stage 2413786 Abandoned
NCI E-059-2001-0-US-01 Transforming Growth Factor Beta(TGF-BETA) Antagonist Selectively Neutralize PATHOLOGICAL TGF BETA. US 60/300,087 Abandoned
NIDDK E-213-2001-0-US-01 Anticancer Effects of a Novel Vitamin D Receptor Antagonists US 60/299,570 Abandoned
NCI E-058-2001-0-US-01 Human UGRP (Uteroglobin-Related Protein) 1 Promoter And its Use US 60/299,828 Abandoned
NHGRI E-196-2001-0-US-01 Use of Interferon-inducible 2',5'-Oligoadenylate-dependent RNase L in The Diagnosis, Prognosis And Treatment of Cancer US 60/299,664 Abandoned
NINDS E-288-1999-0-US-02 Methods of Protecting Vasculature From Damage by Diphtheria Toxin- and Pseudomonas Toxin-Based Immunotoxins during Therapy US ORD 09/884,695 6696064 Abandoned PDF
NIAID E-122-2001-0-US-01 Anti-Arthropod Vector Vaccines,Methods of Selecting and Uses Thereof US 60/299,391 Abandoned